Medtronic today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) technologies.

In connection with the Heart Rhythm Society’s 2025 meeting in San Diego, which wrapped this weekend, Boston Scientific, ...

Nitinol innovation in cardiac medtech is not slowing down in 2025, with innovative devices and systems hitting milestones and ...

The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting.

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA ... 9™ catheter demonstrates efficacy for linear ablation in persistent AFib Medtronic ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

The Parkview Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to ...

For more information on the Affera PFA system and the Sphere-9 catheter, visit Medtronic.com. Any forward-looking statements are subject to risks and uncertainties such as those described in ...

For more information on the Affera PFA system and the Sphere-9 catheter, visit Medtronic. Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland ...